Notificação de entrada na fase nacional - PCT
#1.3
07/21/2026
RPI 2898
Application data
Number
112025019201Type
Filing
Publication
PCT
US2024019883 Examination has not been requested yet. Without that request by 03/14/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:03/14/2027(201 days left)
Latest action published by the INPI: 07/21/2026. We update with every new RPI gazette, published weekly.
Applicants
VIKING THERAPEUTICS, INC.
US
Inventors
B. L. (pessoa física)
US
G. B. (pessoa física)
US
J. G. (pessoa física)
US
K. Y. (pessoa física)
US
M. B. (pessoa física)
US
IPC Classification
Priority claims
US
63/490,512 · 03/15/2023
Abstract
São descritas neste documento composições orais de agonistas de pequenas moléculas de GLP-1 e agonistas de receptores duplos de GIP/GLP-1 e usos das mesmas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
07/21/2026
RPI 2898
#1.1
09/23/2025
RPI 2855
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.